Macquarie Group’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-38,000
| Closed | -$2.58M | – | 1995 |
|
|
2019
Q3 | $2.58M | Hold |
38,000
| – | – | ﹤0.01% | 958 |
|
|
2019
Q2 | $2.21M | Hold |
38,000
| – | – | ﹤0.01% | 988 |
|
|
2019
Q1 | $2.66M | Sell |
38,000
-200
| -0.5% | -$14.8K | ﹤0.01% | 916 |
|
|
2018
Q4 | $2.46M | Buy |
38,200
+200
| +0.5% | +$14K | ﹤0.01% | 911 |
|
|
2018
Q3 | $2.67M | Hold |
38,000
| – | – | ﹤0.01% | 931 |
|
|
2018
Q2 | $1.92M | Hold |
38,000
| – | – | ﹤0.01% | 1007 |
|
|
2018
Q1 | $1.19M | Hold |
38,000
| – | – | ﹤0.01% | 1129 |
|
|
2017
Q4 | $1.3M | Hold |
38,000
| – | – | ﹤0.01% | 1168 |
|
|
2017
Q3 | $1.22M | Hold |
38,000
| – | – | ﹤0.01% | 1150 |
|
|
2017
Q2 | $1.24M | Hold |
38,000
| – | – | ﹤0.01% | 1101 |
|
|
2017
Q1 | $1.2M | Hold |
38,000
| – | – | ﹤0.01% | 1130 |
|
|
2016
Q4 | $1.12M | Sell |
38,000
-17,000
| -31% | -$518K | ﹤0.01% | 1132 |
|
|
2016
Q3 | $1.59M | Sell |
55,000
-55,000
| -50% | -$1.53M | ﹤0.01% | 1024 |
|
|
2016
Q2 | $2.85M | Buy |
110,000
+55,000
| +100% | +$1.46M | ﹤0.01% | 1056 |
|
|
2016
Q1 | $1.36M | Hold |
55,000
| – | – | ﹤0.01% | 1050 |
|
|
2015
Q4 | $1.94M | Hold |
55,000
| – | – | ﹤0.01% | 938 |
|
|
2015
Q3 | $1.16M | Hold |
55,000
| – | – | ﹤0.01% | 1101 |
|
|
2015
Q2 | $1.53M | Buy |
55,000
+17,420
| +46% | +$491K | ﹤0.01% | 1089 |
|
|
2015
Q1 | $1.15M | Buy |
+37,580
| New | +$1.19M | ﹤0.01% | 1128 |
|
Macquarie Group's GHDX Position: Q4 2019 in Review
Macquarie Group sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 38,000 shares — an estimated $2.58M sold.
Macquarie Group first reported a position in GHDX in Q1 2015 and held it in 19 quarters. The position peaked at $2.85M in Q2 2016. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- Macquarie Group reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- Macquarie Group sold 38,000 Genomic Health, Inc. shares in Q4 2019, an estimated $2.58M.
- Macquarie Group first reported a position in Genomic Health, Inc. in Q1 2015 and held it in 19 quarters.
- Macquarie Group's Genomic Health, Inc. position peaked at $2.85M in Q2 2016.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on Macquarie Group's 13F filing for Q4 2019, filed 14 Feb 2020.